Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-09-07

Clinical Trial Update: PRISM Cardiac Resynchronisation Therapy (CRT) Randomised Controlled Trial [Phase 2, Phase 3]

View source ↗

Summary

This entry reports a Phase 2/Phase 3 randomized trial evaluating cardiac resynchronisation therapy for heart failure. It is sponsored by Guy's and St Thomas' NH…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Heart Failure | Phase 2, Phase 3 | Status: UNKNOWN